Post-stroke statin use linked to lower fracture risk
Patients treated with statins after a stroke show lower incidence of fractures, a study in the Journal of Clinical Metabolism reports.Healio
The objective of this study was to investigate the effects of statin use before cardiac arrest on outcomes in cardiac arrest patients. Medical records of 142,131 adult patients who experienced non-traumatic cardiac arrest and were resuscitated between 2004 and 2011 were analyzed.
To determine the effects of statin use on coronary artery disease (CAD) and stroke risks in patients with asthma –chronic obstructive pulmonary disease overlap syndrome (ACOS).
ConclusionsThe CVD event rate is high among African Americans and whites meeting the FOURIER inclusion criteria. Characteristics associated with a higher CVD risk may inform the decision to initiate PCSK9 inhibition.
We describe three patients treated with PCSK9 inhibitor alirocumab for progressive carotid stenosis despite lipid-lowering statin therapy. All three patients had vulnerable plaques on magnetic resonance (MR) plaque imaging. After alirocumab treatment initiation, no patients suffered stroke or adverse events, and the stabilization of the carotid plaques was observed on MR plaque imaging.
(Natural News) Statin drugs, prescribed by doctors to reduce high cholesterol levels and supposedly prevent heart attacks and strokes, are the second most prescribed drugs in the world, after the painkiller hydrocodone. Since one in five Americans between the ages of 40 and 75 take these drugs regularly, it is likely that you are acquainted...
The regular reviews will cut problematic polypharmacy and save money Related items fromOnMedica Stroke survivors need more help taking medicine GPs defend practice on prescribing statins Multidisciplinary prescribing can help reduce errors Guidance issued on prescribing responsibilities Call for NHS England to ‘think again’ on limiting treatment
Publication date: 2–8 February 2019Source: The Lancet, Volume 393, Issue 10170Author(s): Jane Armitage, Colin Baigent, Elizabeth Barnes, D John Betteridge, Lisa Blackwell, Michael Blazing, Louise Bowman, Eugene Braunwald, Robert Byington, Christopher Cannon, Michael Clearfield, Helen Colhoun, Rory Collins, Björn Dahlöf, Kelly Davies, Barry Davis, James de Lemos, John R Downs, Paul Durrington, Jonathan EmbersonSummaryBackgroundStatin therapy has been shown to reduce major vascular events and vascular mortality in a wide range of individuals, but there is uncertainty about its efficacy and safety among older ...
Statin therapy reduces major vascular events, such as heart attacks and strokes, in a wide range of people, including those over the age of 75, according to new research from MRC scientists.
Pooled data analysis shows their benefit even in those older than 75 Related items fromOnMedica Too few women take part in many CVD clinical trials Women less likely than men to achieve CHD targets Statins safe and effective Scientists redefine how plaque grows in the heart Never too old to benefit from CVD prevention
Offering statins to all over-75s could prevent 8,000 deaths from heart failure and stroke, researchers sayThousands of deaths and the wrecking of many lives by disability could be averted if doctors routinely offered a daily statin pill to older people, scientists say.They blame misinformation about the side-effects of statins, together with society ’s ageism, for the low uptake among older people, who are at highest risk of heart attacks, heart failure and stroke.Continue reading...